Patents by Inventor Namvar Kiaie

Namvar Kiaie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9501272
    Abstract: Embodiments described herein include methods and/or systems for updating a medical device. Embodiments include medical devices which are configured for updates in response to various events including connection of a peripheral device to the medical device, a user initiated event, or based on received recommendations.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: November 22, 2016
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Namvar Kiaie, Jean-Pierre Cole
  • Publication number: 20160015268
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.
    Type: Application
    Filed: August 31, 2015
    Publication date: January 21, 2016
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Hung Dinh, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Publication number: 20160015267
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.
    Type: Application
    Filed: August 31, 2015
    Publication date: January 21, 2016
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Hung Dinh, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Publication number: 20160015303
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.
    Type: Application
    Filed: August 31, 2015
    Publication date: January 21, 2016
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Hung Dinh, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Publication number: 20150269340
    Abstract: Medical devices having restrictive access, and methods thereof are provided.
    Type: Application
    Filed: June 3, 2015
    Publication date: September 24, 2015
    Inventors: Christopher V. Reggiardo, Namvar Kiaie, James Thomson
  • Publication number: 20150265192
    Abstract: Embodiments of the present disclosure include detecting a concurrent occurrence of a decrease in monitored analyte level and a corresponding decrease in monitored on-skin temperature, confirming a presence of an impending hypoglycemic condition, and asserting a notification corresponding to the confirmed impending hypoglycemic condition. Devices, methods, systems and kits incorporating the same are also provided.
    Type: Application
    Filed: June 3, 2015
    Publication date: September 24, 2015
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benjamin Jay Feldman, Adam Heller, Namvar Kiaie
  • Patent number: 9064107
    Abstract: Medical devices having restrictive access, and methods thereof are provided.
    Type: Grant
    Filed: September 30, 2013
    Date of Patent: June 23, 2015
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Christopher V. Reggiardo, Namvar Kiaie, James Thomson
  • Patent number: 9050041
    Abstract: Embodiments of the present disclosure include detecting a concurrent occurrence of a decrease in monitored analyte level and a corresponding decrease in monitored on-skin temperature, confirming a presence of an impending hypoglycemic condition, and asserting a notification corresponding to the confirmed impending hypoglycemic condition. Devices, methods, systems and kits incorporating the same are also provided.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: June 9, 2015
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Benjamin Jay Feldman, Adam Heller, Namvar Kiaie
  • Publication number: 20150052511
    Abstract: Embodiments described herein include methods and/or systems for updating a medical device. Embodiments include medical devices which are configured for updates in response to various events including connection of a peripheral device to the medical device, a user initiated event, or based on received recommendations.
    Type: Application
    Filed: October 31, 2014
    Publication date: February 19, 2015
    Inventors: Namvar Kiaie, Jean-Pierre Cole
  • Patent number: 8930203
    Abstract: Methods, device and systems including receiving a request for a therapy profile for treating a medical condition, determining using a processor a plurality of therapy profile parameters, assigning a weighted value to each therapy profile parameter based on a hierarchy determined by the medical condition, querying a database to identify a stored therapy profile with therapy profile parameters that most closely correspond to the determined plurality of therapy profile parameters based on the hierarchy, generating an output data corresponding to the identified stored therapy profile, the output data a medication dosage information are provided. Also provided are systems and kits.
    Type: Grant
    Filed: February 3, 2010
    Date of Patent: January 6, 2015
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Namvar Kiaie, Jean-Pierre Cole, Mark Kent Sloan, Frederic Arbogast
  • Publication number: 20140337826
    Abstract: Embodiments described herein include methods and/or systems for updating a medical device. Embodiments include medical devices which are configured for updates in response to various events including connection of a peripheral device to the medical device, a user initiated event, or based on received recommendations.
    Type: Application
    Filed: May 12, 2014
    Publication date: November 13, 2014
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Namvar Kiaie, Jean-Pierre Cole
  • Patent number: 8887148
    Abstract: Embodiments described herein include methods and/or systems for updating a medical device. Embodiments include medical devices which are configured for updates in response to various events including connection of a peripheral device to the medical device, a user initiated event, or based on received recommendations.
    Type: Grant
    Filed: May 12, 2014
    Date of Patent: November 11, 2014
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Namvar Kiaie, Jean-Pierre Cole
  • Publication number: 20140275910
    Abstract: Methods, device and systems including receiving a request for a therapy profile for treating a medical condition, determining using a processor a plurality of therapy profile parameters, assigning a weighted value to each therapy profile parameter based on a hierarchy determined by the medical condition, querying a database to identify a stored therapy profile with therapy profile parameters that most closely correspond to the determined plurality of therapy profile parameters based on the hierarchy, generating an output data corresponding to the identified stored therapy profile, the output data a medication dosage information are provided. Also provided are systems and kits.
    Type: Application
    Filed: May 30, 2014
    Publication date: September 18, 2014
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Namvar Kiaie, Jean-Pierre Cole, Mark Kent Sloan, Frederic Arbogast
  • Patent number: 8726266
    Abstract: Embodiments described herein include methods and/or systems for updating a medical device. Embodiments include medical devices which are configured for updates in response to various events including connection of a peripheral device to the medical device, a user initiated event, or based on received recommendations.
    Type: Grant
    Filed: May 23, 2011
    Date of Patent: May 13, 2014
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Namvar Kiaie, Jean-Pierre Cole
  • Publication number: 20140107436
    Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include enhanced analyte monitoring devices and systems.
    Type: Application
    Filed: December 18, 2013
    Publication date: April 17, 2014
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Jared Watkin, Martin J. Fennell, Mark Kent Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott
  • Publication number: 20140088382
    Abstract: Methods and devices and systems including a communication module operatively coupled to a data collection module for communicating the stored analyte related data after the analyte related data is stored in the data collection module over a predetermined time period, and a user interface unit configured to communicate with the communication module to receive from the communication module the stored analyte related data in the data collection module over the predetermined time period, and to output information associated with the monitored analyte level, where the user interface unit is configured to operate in a prospective analysis mode including substantially real time output of information associated with the monitored analyte level, or a retrospective analysis mode including limited output of information during the predetermined time period wherein no information related to the monitored analyte level is output during the predetermined time period, are provided.
    Type: Application
    Filed: December 2, 2013
    Publication date: March 27, 2014
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Jared Watkin, Martin J. Fennell, Mark Kent Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott
  • Publication number: 20140081107
    Abstract: Methods, devices, systems, and kits are provided that buffer the time spaced glucose signals in a memory, and when a request for real time glucose level information is detected, transmit the buffered glucose signals and real time monitored glucose level information to a remotely located device, process a subset of the received glucose signals to identify a predetermined number of consecutive glucose data points indicating an adverse condition such as an impending hypoglycemic condition, confirm the adverse condition based on comparison of the predetermined number of consecutive glucose data points to a stored glucose data profile associated with the adverse condition, where confirming the adverse condition includes generating a notification signal when the impending hypoglycemic condition is confirmed, and activate a radio frequency (RF) communication module to wirelessly transmit the generated notification signal to the remotely located device only when the notification signal is generated.
    Type: Application
    Filed: September 16, 2013
    Publication date: March 20, 2014
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Jean-Pierre Cole, Namvar Kiaie
  • Publication number: 20140033303
    Abstract: Medical devices having restrictive access, and methods thereof are provided.
    Type: Application
    Filed: September 30, 2013
    Publication date: January 30, 2014
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Christopher V. Reggiardo, Namvar Kiaie, James Thomson
  • Patent number: 8617069
    Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include enhanced analyte monitoring devices and systems.
    Type: Grant
    Filed: June 20, 2008
    Date of Patent: December 31, 2013
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Daniel Bernstein, Jared Watkin, Martin J. Fennell, Mark K. Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott
  • Patent number: 8597188
    Abstract: Methods and devices and systems including a data collection module for receiving and storing analyte data over a predetermined time period from a subject, a user interface unit coupled to the data collection module for providing one or more indication related to the analyte data, a control unit coupled to the data collection module and the user interface unit to control, at least in part the operation of the data collection module and the user interface unit, a communication module coupled to the control unit for communicating one or more signals associated with the analyte data to a remote location, where the user interface unit is configured to operate in a prospective analysis mode including substantially real time output of the analyte level received by the data collection module, and a retrospective analysis mode including limited output of information to the subject during the predetermined time period, and further where the communication module is configured to communicate with the remote location afte
    Type: Grant
    Filed: June 20, 2008
    Date of Patent: December 3, 2013
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Daniel Bernstein, Jared Watkin, Martin J. Fennell, Mark K. Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott